Name | Number of supported studies | Average coverage | |
---|---|---|---|
retina horizontal cell | 5 studies | 36% ± 6% | |
astrocyte | 5 studies | 29% ± 8% | |
B cell | 4 studies | 21% ± 1% | |
precursor B cell | 4 studies | 34% ± 7% | |
endothelial cell of lymphatic vessel | 4 studies | 28% ± 11% | |
GABAergic neuron | 3 studies | 30% ± 10% | |
glutamatergic neuron | 3 studies | 32% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 2733.83 | 2593 / 2642 | 99% | 41.70 | 700 / 705 |
thymus | 99% | 1181.14 | 645 / 653 | 90% | 10.31 | 547 / 605 |
liver | 99% | 2124.19 | 223 / 226 | 67% | 11.43 | 274 / 406 |
breast | 99% | 2452.69 | 454 / 459 | 59% | 4.09 | 658 / 1118 |
adrenal gland | 95% | 921.10 | 246 / 258 | 57% | 9.76 | 131 / 230 |
pancreas | 52% | 280.47 | 172 / 328 | 92% | 18.58 | 163 / 178 |
kidney | 78% | 814.20 | 69 / 89 | 48% | 3.30 | 434 / 901 |
esophagus | 50% | 314.39 | 728 / 1445 | 58% | 3.98 | 106 / 183 |
prostate | 44% | 245.00 | 108 / 245 | 61% | 3.86 | 308 / 502 |
skin | 61% | 406.57 | 1110 / 1809 | 41% | 5.04 | 192 / 472 |
adipose | 100% | 3245.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 210.60 | 29 / 29 |
spleen | 100% | 5459.97 | 241 / 241 | 0% | 0 | 0 / 0 |
intestine | 42% | 446.25 | 407 / 966 | 45% | 4.58 | 237 / 527 |
uterus | 21% | 205.81 | 35 / 170 | 59% | 4.85 | 270 / 459 |
ovary | 16% | 90.96 | 28 / 180 | 62% | 4.53 | 267 / 430 |
lung | 38% | 212.94 | 221 / 578 | 39% | 2.96 | 453 / 1155 |
stomach | 22% | 118.21 | 79 / 359 | 48% | 5.51 | 138 / 286 |
tonsil | 0% | 0 | 0 / 0 | 56% | 3.89 | 25 / 45 |
bladder | 14% | 93.29 | 3 / 21 | 27% | 3.11 | 138 / 504 |
peripheral blood | 35% | 491.20 | 329 / 929 | 0% | 0 | 0 / 0 |
heart | 28% | 156.44 | 242 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 13% | 115.15 | 176 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 9% | 0.80 | 7 / 80 |
muscle | 4% | 18.29 | 29 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0016567 | Biological process | protein ubiquitination |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0045581 | Biological process | negative regulation of T cell differentiation |
GO_0010001 | Biological process | glial cell differentiation |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0008593 | Biological process | regulation of Notch signaling pathway |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0030217 | Biological process | T cell differentiation |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005112 | Molecular function | Notch binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | DTX1 |
Protein name | E3 ubiquitin-protein ligase DTX1 (EC 2.3.2.27) (Protein deltex-1) (Deltex1) (hDTX1) (RING-type E3 ubiquitin transferase DTX1) |
Synonyms | |
Description | FUNCTION: Functions as a ubiquitin ligase protein in vivo, mediating ubiquitination and promoting degradation of MEKK1, suggesting that it may regulate the Notch pathway via some ubiquitin ligase activity (By similarity). Regulator of Notch signaling, a signaling pathway involved in cell-cell communications that regulates a broad spectrum of cell-fate determinations. Mainly acts as a positive regulator of Notch, but it also acts as a negative regulator, depending on the developmental and cell context. Mediates the antineural activity of Notch, possibly by inhibiting the transcriptional activation mediated by MATCH1. Involved in neurogenesis, lymphogenesis and myogenesis, and may also be involved in MZB (Marginal zone B) cell differentiation. Promotes B-cell development at the expense of T-cell development, suggesting that it can antagonize NOTCH1. . |
Accessions | Q86Y01 ENST00000257600.3 ENST00000548759.2 |